rs9858278
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_207015.3(NAALADL2):c.1897-419T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.409 in 152,036 control chromosomes in the GnomAD database, including 15,888 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.41 ( 15888 hom., cov: 33)
Consequence
NAALADL2
NM_207015.3 intron
NM_207015.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.97
Publications
4 publications found
Genes affected
NAALADL2 (HGNC:23219): (N-acetylated alpha-linked acidic dipeptidase like 2) Predicted to enable metalloexopeptidase activity. Predicted to be involved in proteolysis. Predicted to act upstream of or within response to bacterium. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.721 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NAALADL2 | NM_207015.3 | c.1897-419T>C | intron_variant | Intron 11 of 13 | ENST00000454872.6 | NP_996898.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NAALADL2 | ENST00000454872.6 | c.1897-419T>C | intron_variant | Intron 11 of 13 | 1 | NM_207015.3 | ENSP00000404705.1 |
Frequencies
GnomAD3 genomes AF: 0.409 AC: 62059AN: 151918Hom.: 15854 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
62059
AN:
151918
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.409 AC: 62149AN: 152036Hom.: 15888 Cov.: 33 AF XY: 0.402 AC XY: 29894AN XY: 74334 show subpopulations
GnomAD4 genome
AF:
AC:
62149
AN:
152036
Hom.:
Cov.:
33
AF XY:
AC XY:
29894
AN XY:
74334
show subpopulations
African (AFR)
AF:
AC:
30184
AN:
41472
American (AMR)
AF:
AC:
5221
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
1208
AN:
3470
East Asian (EAS)
AF:
AC:
472
AN:
5172
South Asian (SAS)
AF:
AC:
1316
AN:
4830
European-Finnish (FIN)
AF:
AC:
2615
AN:
10564
Middle Eastern (MID)
AF:
AC:
132
AN:
292
European-Non Finnish (NFE)
AF:
AC:
20015
AN:
67926
Other (OTH)
AF:
AC:
827
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1596
3192
4789
6385
7981
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
530
1060
1590
2120
2650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
849
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.